Inhibition of 26S protease regulatory subunit 7 (MSS1) suppresses neuroinflammation

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Bi, Wei ^a,b   Jing, Xiuna ^a   Zhu, Lihong ^c   Liang, Yanran ^a   Liu, Jun ^a   Yang, Lianhong ^a   Xiao, Songhua ^a   Xu, Anding ^b   Shi, Qiaoyun ^d   Tao, Enxiang ^a  

^a SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF JINAN UNIVERSITY   (China)

^c JINAN UNIVERSITY   (China)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

26S PROTEASE REGULATORY SUBUNIT 7; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PROSTAGLANDIN E2; PROTEINASE; RIFAMPICIN; UNCLASSIFIED DRUG;

26S PROTEASE REGULATORY SUBUNIT 7 GENE; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DOWN REGULATION; ENZYME INHIBITION; GENE; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE SILENCING; MASS SPECTROMETRY; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUROMODULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RNA INTERFERENCE; RNA SEQUENCE; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ANIMALS; CELL LINE; CELLS, CULTURED; GENE SILENCING; I-KAPPA B PROTEINS; INFLAMMATION; MICE; MICROGLIA; NF-KAPPA B; PROTEASOME ENDOPEPTIDASE COMPLEX; RIFAMPIN; RNA, SMALL INTERFERING;

EID: 84861569658     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036142     Document Type: Article

References (40)

1. Liu B, Hong JS, (2003) Role of microglia in inflammation-mediated neurodegenerative diseases: mechamisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 304: 1-7.
2. Eikelenboom P, van Gool WA, (2004) Neuroinflammatory perspectives on the two faces of Alzheimer's disease. J Neural Transm 111: 281-294.
3. Koning N, Bö L, Hoek RM, Huitinga I, (2007) Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions. Ann Neurol 62: 504-514.
4. Krause DL, Müller N, (2010) Neuroinflammation, microglia and implications for anti-inflammatory treatment in Alzheimer's disease. Int J Alzheimers Dis 2010. pii, 732806.
5. Qian L, Flood PM, Hong JS, (2010) Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy. J Neural Transm 117: 971-979.
6. Blanchard JS, (1998) The ying and yang of rifampicin. Nat Med 4: 92-96.
7. Bellahsène A, Forsgren A, (1980) Effect of rifampin on the immune response in mice. Infect Immun 27: 15-20.
8. Tsankov N, Grozdev I, Kkzandjieva J, (2006) Old drug-new indication. Rifampicin in psoriasis. J Dermatolog Treat 17: 18-23.
9. Tsiskarishvili NV, Tsiskarishvili NI, (2009) The anti-tubercular drugs in the treatment of psoriasis.Georgian Med News 174: 25-28.
10. Namazi HJ, (2008) Practice pearl: a novel use of rifampicin for treatment of carpal tunnel syndrome. Pain 9: 380-381.
11. Xu J, Wei C, Xu C, Bennett MC, Zhang G, et al. (2007) Rifampicin protects PC12 cells against MPP+-induced apoptosis and inhibits the expression of an alpha-Synuclein multimer. Brain Res 1139: 220-225.
12. Bi W, Zhu L, Wang C, Liang Y, Liu J, et al. (2011) Rifampicin inhibits microglial inflammation and improves neuron survival against inflammation. Brain Res 1395: 12-20.
13. Dai JN, Zong Y, Zhong LM, Li YM, Zhang W, (2011) Gastrodin inhibits expression of inducible NO synthase, cyclooxygenase-2 and pro-flammatory cytokines in cultured LPS-stimulated microglia via MAPK pathways. PLoS One 6: e21891.
14. S Vallabhapurapu, M Karin, (2009) Regulation and function of NF-kappaB transcription factors in the immune system, Annu. Rev. Immunol 27: 693-733.
15. Zhang W, Wei Q, (2011) Calcineurin stimulates the expression of inflammatory factors in RAW 264.7 cells by interacting with proteasome subunit alpha type 6. Biochem Biophys Res Commun 407: 668-673.
16. De Mot R, Nagy I, Walz J, Baumeister W, (1999) Proteasomes and other self-compartmentalizing proteases in prokaryotes. Trends Microbiol 7: 88-92.
17. Williams AJ, Dave JR, Tortella FC, (2006) Neuroprotection with the proteasome inhibitor MLN519 in focal ischemic brain injury: relation to nuclear factor kappaB (NF-kappaB), inflammatory gene expression, and leukocyte infiltration. Neurochem Int 49: 106-12.
18. Yanagi S, Shimbara N, Tamura T, (2000) Tissue and cell distribution of a mammalian proteasomal ATPase, MSS1, and its complex formation with the basal transcription factors. Biochem Biophys Res Commun 279: 568-573.
19. Wang Y, Cheung YH, Yang Z, Chiu JF, Che CM, et al. (2006) Proteomic approach to study the cytotoxicity of dioscin (saponin). Proteomics 6: 2422-2432.
20. Jessie K, Pang WW, Haji Z, Rahim A, Hashim OH, (2010) Proteomic analysis of whole human saliva detects enhanced expression of interleukin-1 receptor antagonist,thioredoxin and lipocalin-1 in cigarette smokers compared to non-smokers. International Journal of Molecular Sciences 11: 4488-4505.
21. Tsikas D, (2007) Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: appraisal of the Griess reaction in the L-arginine/nitric oxide area of research. J Chromatogr B Analyt Technol Biomed Life Sci 15; 851 (1-2): 51-70.
22. Woo MS, Jang PG, Park JS, Kim, WK, Jon TH, et al. (2003) Selective modulation of lipopolysaccharide-stimulated cytokine expression and mitogen-activated protein kinase pathways by dibutyryl-cAMP in BV2 microglial cells. Molecular Brain Res 113: 86-96.
23. Dajani BM, Canadi MS, Thompson JS, Kasik JE, (1972) Rifampicin: an immunosuppressant? Lancet 2: 1904.
24. Tsankov N, Angelova I, (2003) Rifampin in dermatology. Clin Dermatol 21: 50-55.
25. Mlambo G, Sigola LB, (2003) Rifampicin and dexamethasone have similar effects on macrophage phagicytosis of zymosan, but differ in their effects on nitrite and TNF-alpha production. Int Immunopharmacol 3: 513-522.
26. An N, Song Y, Zhang X, Ci X, Li H, et al. (2008) Pretreatment of mice with rifampicin prolongs survival of endotoxic shock by modulating the levels of inflammatory cytokines. Immunopharmacol Immunotoxicol 30: 437-446.
27. An N, Song Y, Zhang X, Ci X, Li H, et al. (2005) Group B streptococci exposed to rifampin or clindamycin (versus ampicillin or cefotaxime) stimulate reduced production of inflammatory mediators by murine macrophages. Pediatr Res 57: 419-423.
28. Calleja C, Pascussi JM, Mani JC, Maurel P, Vilarem MJ, (1998) The antibiotic rifampicin is a nonsteroidal ligand and activator of the human glucocorticoid receptor. Nat Med 4: 92-96.
29. Kim SK, Kim YM, Yeum CE, Jin SH, Chae GT, et al. (2009) Rifampicin Inhibits the LPS-induced Expression of Toll-like Receptor 2 via the Suppression of NF-kappaB DNA-binding Activity in RAW 264.7 Cells. Korean J Physiol Pharmacol 13: 475-482.
30. Hershko A, Ciechanover A, (1998) The ubiquitin system. Annu Rev Biochem 67: 425-479.
31. Finley D, (2009) Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem 78: 477-513.
32. Goldberg AL, (2003) Protein degradation and protection against misfolded or damaged proteins. Nature 426: 895-899.
33. Sujashvili R, (2008) Ubiquitin-26s proteasome system. New therapeutic implications. Georgian Med News 161: 48-51.
34. Yanagi S, Shimbara N, Tamur T, (2000) Tissue and cell distribution of a mammalian proteasomal ATPase, MSS1, and its complex formation with the basal transcription factors. Biochem Biophys Res Commun 279: 568-573.
35. Ozato K, Tsujimura H, Tamura T, (2002) Toll-like receptor signal in gand regulation of cytokine gene expression in the immune system. Biotechniques 66-72.
36. Kim WG, Mohney RP, Wilson B, Jeohn GH, Liu B, et al. (2000) Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J Neurosci 20: 6309-6316.
37. Saccani S, Marazzi I, Beg A, Natoli G, (2004) Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response. J Exp Med 200: 107-113.
38. Chen F, Lu Y, Kuhn DC, Maki M, Shi X, et al. (1997) Calpain Contributes to Silica-Induced IkBa Degradation and Nuclear Factor-kB Activation. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 342: 383-388.
39. YmamotoY, Gaynor RB, (2004) IkappaB kinases: key regulators of the NF-kappaB Pathway. Trends Biochem Sci 29: 72-79.
40. Wang Y, Yu C, Pan Y, Li J, Zhang Y, et al. (2011) A novel compound c12 inhibits inflammatory cytokine production and protects from inflammatory injury in vivo. PLoS One 6: e24377.